Type II diabetes mellitus

October 30, 2023

Pseudocannabinoid H4CBD improves glucose response during advanced metabolic syndrome in OLETF rats independent of increase in insulin signaling proteins

Abstract Cannabidiol (CBD) use has grown exponentially more popular in the last two decades, particularly among older adults (>55 yr),…

June 23, 2021

Evaluation of cannabidiol’s inhibitory effect on alpha-glucosidase and its stability in simulated gastric and intestinal fluids

Abstract Objective: Cannabidiol (CBD) has been reported to have anti-diabetic effects in pre-clinical and clinical studies but its inhibitory effects…

October 26, 2020

Protective Effects of (E)-β-Caryophyllene (BCP) in Chronic Inflammation

Abstract (E)-β-caryophyllene (BCP) is a bicyclic sesquiterpene widely distributed in the plant kingdom, where it contributes a unique aroma to…